Anticancer activity of the PR domain of tumor suppressor RIZ1

International Journal of Medical Sciences

Volumn 8, Issue 2, 2011, Pages 161-167

  Sun, Wanpeng ^a   Qiao, Ling ^b   Liu, Qiang ^b   Chen, Lifeng ^a   Ling, Binbing ^a   Sammynaiken, Ramaswami ^c   Yang, Jian ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Human tumor suppressor; RIZ; RIZ1; Tumor metastasis

Indexed keywords

MESSENGER RNA; ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN;

AMINO TERMINAL SEQUENCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER STAGING; CELL FUNCTION; COLON CANCER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; METASTASIS; OVARY CANCER; PR DOMAIN; PROSTATE CANCER; PROTEIN STRUCTURE; THYROID CANCER; TUMOR SUPPRESSOR GENE;

EID: 79951793879     PISSN: None     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.8.161     Document Type: Article

References (33)

1. Jiang G, Liu L, Buyse IM, Simon D, Huang S. Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of he-patoma tumorigenicity by RIZ1. Int J Cancer 1999; 83: 541-6.
2. Jiang GL, Huang S. The yin-yang of PR-domain family genes in tumorigenesis. Histol Histopathol 2000; 15: 109-17.
3. Buyse IM, Takahashi EI, Huang S. Physical mapping of the retinoblastoma interacting zinc finger gene RIZ to D1S228 on chromosome 1p36. Genomics 1996; 34: 119-21.
4. He L, Yu JX, Liu L, Buyse IM, Wang MS, Yang QC, Nakagawara A, Brodeur GM, Shi YE, Huang S. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle ar-rest and/or apoptosis. Cancer Res 1998; 58: 4238-44.
5. Chadwick RB, Jiang GL, Bennington GA, Yuan B, Johnson CK, Stevens MW, Niemann TH, Peltomaki P, Huang S, de la Chapelle A. Candidate tumor suppressor RIZ is frequently in-volved in colorectal carcinogenesis. Proc Natl Acad Sci USA 2000; 97: 2662-7.
6. Sasaki O, Meguro K, Tohmiya Y, Funato T, Shibahara S, Sasaki T. Altered expression of retinoblastoma protein-interacting zinc finger gene, RIZ, in human leukaemia. Br J Haematol 2002; 119: 940-8.
7. Lal G, Padmanabha L, Smith BJ, Nicholson RM, Howe JR, O'Dorisio MS, Domann FE Jr. RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma. Cancer 2006; 107: 2752-9.
8. Piao GH, Piao WH, He Y, Zhang HH, Wang GQ, Piao Z. Hy-per-methylation of RIZ1 tumor suppressor gene is involved in the early tumorigenesis of hepatocellular carcinoma. Histol Histopathol 2008; 23: 1171-5.
9. Liu L, Shao G, Steele-Perkins G, Huang S. The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter. J Biol Chem 1997; 272: 2984-91.
10. Du Y, Carling T, Fang W, Piao Z, Sheu JC, Huang S. Hyper-methylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase super-family. Cancer Res 2001; 61: 8094-9.
11. Jiang GL, Huang S. Adenovirus expressing RIZ1 in tumor suppressor gene therapy of microsatellite-unstable colorectal cancers. Cancer Res. 2001; 61: 1796-8.
12. Deng Q, Huang S. PRDM5 is silenced in human cancers and has growth suppressive activities. Oncogene 2004; 17: 4903-10.
13. Mori N, Morosetti R, Spira S, Lee S, Ben-Yehuda D, Schiller G, Landolfi R, Mizoguchi H, Koeffler HP. Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Blood 1998; 92: 3405-9.
14. Tam W, Gomez MF, Chadburn A, Knowles DM, Houldsworth J. Lack of A563G (I188V) missense mutation in RIZ/ PR in hu-man diffuse large B-cell lymphomas. Genes Chromosomes Cancer 2007; 46: 416-8.
15. Kim KC, Huang S. Histone methyltransferases in tumor sup-pression. Cancer Biol Ther 2003; 2: 491-9.
16. Huang S, Shao G, Liu L. The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression. J Biol Chem 1998; 273: 15933-9.
17. Canote R, Du Y, Carling T, Tian F, Peng Z, Huang S. The tumor suppressor gene RIZ in cancer gene therapy (review). Oncol Rep 2002; 9: 57-60.
18. Watanabe Y, Toyota M, Kondo Y, Suzuki H, Imai T, Ohe-Toyota M, Maruyama R, Nojima M, Sasaki Y, Sekido Y, Hiratsuka H, Shinomura Y, Imai K, Itoh F, Tokino T. PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer. Clin Cancer Res 2007; 13: 4786-94.
19. Derunes C, Briknarová K, Geng L, Li S, Gessner CR, Hewitt K, Wu S, Huang S, Woods VI Jr, Ely KR. Characterization of the PR domain of RIZ1 histone methyltransferase. Biochem Biophys Res Commun 2005; 333: 925-34.
20. Sun W, Geyer CR, Yang J. Cloning, expression, purification and crystallization of the PR domain of human retinoblastoma pro-tein-binding zinc finger protein 1 (RIZ1). Int J Mol Sci 2008; 9: 943-50.
21. Chen L, Ling B, Alcorn J, Yang J. Analysis of the expression of human N-myristoyltransferase 1 (hNMT-1) in cancers. Open Biomarkers J 2009; 2: 6-10.
22. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456-67.
23. Pastural E, Takahashi N, Dong WF, Bainbridge M, Hull A, Pearson D, Huang S, Lowsky R, DeCoteau JF, Geyer CR. RIZ1 repression is associated with insulin-like growth factor-1 sig-naling activation in chronic myeloid leukemia cell lines. Onco-gene 2007; 26: 1586-94.
24. Noman AS, Koide N, Iftakhar-E-Khuda I, Dagvadorj J, Tu-murkhuu G, Naiki Y, Komatsu T, Yoshida T, Yokochi T. Reti-noblastoma protein-interacting zinc finger 1 (RIZ1) participates in RANKL-induced osteoclast formation via regulation of NFATc1 expression. Immunol Lett 2010; 131:166-9.
25. Miyake H, Hara I, Yamanaka K, Muramaki M, Gleave M, Eto H. Introduction of insulin-like growth factor binding protein-2 gene into human bladder cancer cells enhances their metastatic potential. Oncol Rep 2005; 13: 341-5.
26. Wang H, Arun BK, Wang H, Fuller GN, Zhang W, Middleton LP, Sahin AA. IGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas. Breast J 2008; 14: 261-7.
27. Porte H, Chastre E, Prevot S, Nordlinger B, Empereur S, Basset P, Chambon P, Gespach C. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes. Int J Cancer 1995; 64: 70-5.
28. Wang CS, Lin KH, Chen SL, Chan YF, Hsueh S. Overexpression of SPARC gene in human gastric carcinoma and its clin-ic-pathologic significance. Br J Cancer 2004; 91: 1924-30.
29. Yiu GK, Toker A. NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2. J Biol Chem 2006; 281:12210-7.
30. Stapleton D, Balan I, Pawson T, Sicheri F. The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization. Nat Struct Biol 1999; 6: 44-9.
31. Brantley-Sieders DM, Fang WB, Hwang Y, Hicks D, Chen J. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA recep-tor and vascular endothelial growth factor in mice. Cancer Res 2006; 66: 10315-24.
32. Pasquale EB. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer 2010; 10: 165-80.
33. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts. Annu Rev Med 2007; 58: 267-84.